Help us make childhood cancer universally survivable.
By giving monthly, you directly support our continued research into discovering effective and less toxic treatments for childhood cancer.
Support Our Lab
Our team is on a mission to make childhood cancer universally survivable!
The FDA approves on average 12 drugs every year to treat adult cancer, but has only approved 10 drugs to treat childhood cancer since 1978 (10 in 44 years for kids).
Since our inception in 2015, cc-TDI has pushed two drugs into three clinical trials to treat childhood cancer.
giving back childhood for
#GIVINGBACKCHILDHOOD
Latest News
![](https://cc-tdi.org/wp-content/uploads/2023/08/Claire-Headshot_IMG_9047.1-881x1024.jpg)
Claire Newman appointed new Executive Director
The Children’s Cancer Therapy Development Institute (cc-TDI) is delighted to welcome former Intel Executive, Claire Newman, as their new Executive Director on July 1st. Claire first joined cc-TDI in August 2023 through Intel’s Encore Social Venture Partner Fellowship program focusing on scaling and optimization of cc-TDI’s growing organization. Over the past year she has had the opportunity to experience firsthand the dedication and talent of the cc-TDI team while assessing areas in which her enterprise-level experience could further cc-TDI’s critical childhood cancer research mission. Scientific Director, Dr. Charles Keller explains, “Claire is an easy fit
![](https://cc-tdi.org/wp-content/uploads/2024/06/2024-HS-Dan-and-I-with-Bills-picture-1-300x225.jpg)
![](https://cc-tdi.org/wp-content/uploads/2024/05/cc-TDI-Anniversary-300x300.png)
cc-TDI Celebrates First Year
![](https://cc-tdi.org/wp-content/uploads/2024/05/IMG_0395-233x300.jpeg)
Inspired Through Love
![](https://cc-tdi.org/wp-content/uploads/2024/05/Social-Image-Promo-cc-TDI-Impact-Report-300x300.png)
cc-TDI’s 2023 Impact Report
In the Press
Current Research Projects
![](https://cc-tdi.org/wp-content/uploads/2018/08/cc-tdi-group2-1024x582.jpg)
A dedicated research team
Our research team is exploring and testing state-of-the-art treatment options for the most urgent issues facing children with cancer.
Working in our own freestanding research institution allows us to act swiftly and nimbly to achieve results—bringing cost control, speed, purpose, and focus to translate effective treatments into the clinic. To get there, we perform basic science and translational research in our industrial modern lab site (a paint factory remodeled by Nike as an off-site creative space), adjacent to the Silicon Forest in Oregon.